John W. Shiver's most recent trade in Novavax, Inc. was a trade of 35,770 Stock Option (Right to buy) done . Disclosure was reported to the exchange on March 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Novavax, Inc. | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 35,770 | 35,770 | - | - | Stock Option (Right to buy) | |
Novavax, Inc. | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 23,840 | 23,840 | - | - | Restricted Stock Units | |
Icosavax Inc | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 9,643 | 9,643 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 2,399 | 10,899 | - | 0 | Common Stock | |
Icosavax Inc | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 25,500 | 25,500 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | John W. Shiver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 8,500 | 8,500 | - | 0 | Common Stock |